Neurochemical Research

, Volume 38, Issue 1, pp 153–161 | Cite as

Characterization of Basal and Morphine-Induced Uridine Release in the Striatum: An In Vivo Microdialysis Study in Mice

  • Wu Song
  • Chun-Fu Wu
  • Ping Liu
  • Rong-Wu Xiang
  • Fang Wang
  • Ying-Xu Dong
  • Jing-Yu Yang
Original Paper


Uridine, a pyrimidine nucleoside, has been proposed to be a potential signaling molecule in the central nervous system. The understanding of uridine release in the brain is therefore of fundamental importance. The present study was performed to determine the characteristics of basal and morphine-induced uridine release in the striatum of freely moving mice by using the microdialysis technique. To ascertain whether extracellular uridine was derived from neuronal release, the following criteria were applied: sensitivity to (a) K+ depolarization, (b) Na+ channel blockade and (c) removal of extracellular Ca2+. Uridine levels were not greatly affected by infusion of tetrodotoxin (TTX) and were unaffected by either Ca2+-free medium or in the presence of EGTA (a calcium chelator), suggesting that basal extracellular uridine levels were maintained mainly by non-vesicular release mechanisms. In addition, both systemic and local application of morphine increased striatal uridine release. The morphine-induced release was reversed by naloxone pretreatment, but was unaffected by TTX or EGTA infusion. Moreover, co-administration of morphine and nitrobenzylthioinosine (NBTI, an inhibitor of nucleotide transporter) produced increases of uridine levels similar to that produced by NBTI or morphine alone, suggesting a nucleotide transporter mechanism involved. Taken together, these findings suggest that morphine produces a μ-opioid receptor-mediated uridine release via nucleoside transporters in a TTX- and calcium-independent manner.


Uridine Morphine Microdialysis Naloxone Nucleoside transporter 


  1. 1.
    Yamamoto T, Koyama H, Kurajoh M, Shoji T, Tsutsumi Z, Moriwaki Y (2011) Biochemistry of uridine in plasma. Clin Chim Acta 412:1712–1724PubMedCrossRefGoogle Scholar
  2. 2.
    Dobolyi A, Juhasz G, Kovacs Z, Kardos J (2011) Uridine function in the central nervous system. Curr Top Med Chem 11:1058–1067PubMedCrossRefGoogle Scholar
  3. 3.
    Kimura T, Ho IK, Yamamoto I (2001) Uridine receptor: discovery and its involvement in sleep mechanism. Sleep 24:251–260PubMedGoogle Scholar
  4. 4.
    Kimura-Takeuchi M, Inoue S (1993) Lateral preoptic lesions void slow-wave sleep enhanced by uridine but not by muramyl dipeptide in rats. Neurosci Lett 157:17–20PubMedCrossRefGoogle Scholar
  5. 5.
    Kimura-Takeuchi M, Inoue S (1993) Differential sleep modulation by sequentially administered muramyl dipeptide and uridine. Brain Res Bull 31:33–37PubMedCrossRefGoogle Scholar
  6. 6.
    Zhao Q, Marolewski A, Rusche JR, Holmes GL (2006) Effects of uridine in models of epileptogenesis and seizures. Epilepsy Res 70:73–82PubMedCrossRefGoogle Scholar
  7. 7.
    Roberts CA, Kreisman NR, Waltman M (1974) Uridine anticonvulsant effects: selective control of nucleoside incorporation in experimental epilepsy. Epilepsia 15:479–500PubMedCrossRefGoogle Scholar
  8. 8.
    Peters GJ, Van Groeningen CJ, Laurensse EJ, Lankelma J, Leyva A, Pinedo HM (1987) Uridine-induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolites. Cancer Chemother Pharmacol 20:101–108PubMedCrossRefGoogle Scholar
  9. 9.
    Peters GJ, Van Groeningen CJ, Laurensse E, Kraal I, Leyva A, Lankelma J, Pinedo HM (1987) Effect of pyrimidine nucleosides on body temperatures of man and rabbit in relation to pharmacokinetic data. Pharm Res 4:113–119PubMedCrossRefGoogle Scholar
  10. 10.
    Holguin S, Martinez J, Chow C, Wurtman R (2008) Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. FASEB J 22:3938–3946PubMedCrossRefGoogle Scholar
  11. 11.
    Dobolyi A, Szikra T, Kekesi AK, Kovacs Z, Juhasz G (1999) Uridine is released by depolarization and inhibits unit activity in the rat hippocampus. Neuroreport 10:3049–3053PubMedCrossRefGoogle Scholar
  12. 12.
    Kardos J, Kovacs I, Szarics E, Kovacs R, Skuban N, Nyitrai G, Dobolyi A, Juhasz G (1999) Uridine activates fast transmembrane Ca2+ ion fluxes in rat brain homogenates. Neuroreport 10:1577–1582PubMedCrossRefGoogle Scholar
  13. 13.
    Dobolyi A, Reichart A, Szikra T, Nyitrai G, Kekesi KA, Juhasz G (2000) Sustained depolarisation induces changes in the extracellular concentrations of purine and pyrimidine nucleosides in the rat thalamus. Neurochem Int 37:71–79PubMedCrossRefGoogle Scholar
  14. 14.
    Slezia A, Kekesi AK, Szikra T, Papp AM, Nagy K, Szente M, Magloczky Z, Freund TF, Juhasz G (2004) Uridine release during aminopyridine-induced epilepsy. Neurobiol Dis 16:490–499PubMedCrossRefGoogle Scholar
  15. 15.
    Guarneri P, Guarneri R, La Bella V, Piccoli F (1985) Interaction between uridine and GABA-mediated inhibitory transmission: studies in vivo and in vitro. Epilepsia 26:666–671PubMedCrossRefGoogle Scholar
  16. 16.
    Myers CS, Napolitano M, Fisher H, Wagner GC (1993) Uridine and stimulant-induced motor activity. Proc Soc Exp Biol Med 204:49–53PubMedGoogle Scholar
  17. 17.
    Myers CS, Fisher H, Wagner GC (1995) Uridine reduces rotation induced by L-dopa and methamphetamine in 6-OHDA-treated rats. Pharmacol Biochem Behav 52:749–753PubMedCrossRefGoogle Scholar
  18. 18.
    Kulkarni A, Mcvaugh W, Lawrence B, Pizzini R, Wolinsky I, Vanburen C, Rudolph F, Dafny N (1997) Nutritional supplementation of nucleotides restores opioid CNS-mediated phenomena in mice. Life Sci 61:1691–1696PubMedCrossRefGoogle Scholar
  19. 19.
    Wang TL, Wu CF, Yang JY, Wang F, Song W (2009) Effect of morphine on brain uracil release in mouse striatum detected by microdialysis. Neurosci Lett 457:89–92PubMedCrossRefGoogle Scholar
  20. 20.
    Sun JY, Yang JY, Wang F, Wang JY, Song W, Su GY, Dong YX, Wu CF (2011) Lesions of nucleus accumbens affect morphine-induced release of ascorbic acid and GABA but not of glutamate in rats. Addict Biol 16:540–550PubMedCrossRefGoogle Scholar
  21. 21.
    Van Der Zeyden M, Oldenziel WH, Rea K, Cremers TI, Westerink BH (2008) Microdialysis of GABA and glutamate: analysis, interpretation and comparison with microsensors. Pharmacol Biochem Behav 90:135–147PubMedCrossRefGoogle Scholar
  22. 22.
    Westerink BH, Tuntler J, Damsma G, Rollema H, De Vries JB (1987) The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. Naunyn Schmiedebergs Arch Pharmacol 336:502–507PubMedCrossRefGoogle Scholar
  23. 23.
    Drew KL, O’connor WT, Kehr J, Ungerstedt U (1989) Characterization of gamma-aminobutyric acid and dopamine overflow following acute implantation of a microdialysis probe. Life Sci 45:1307–1317PubMedCrossRefGoogle Scholar
  24. 24.
    Yamashita T (2012) Ca2+-dependent regulation of synaptic vesicle endocytosis. Neurosci Res 73:1–7PubMedCrossRefGoogle Scholar
  25. 25.
    Sarne Y, Fields A, Keren O, Gafni M (1996) Stimulatory effects of opioids on transmitter release and possible cellular mechanisms: overview and original results. Neurochem Res 21:1353–1361PubMedCrossRefGoogle Scholar
  26. 26.
    Yawata A, Matsuhashi Y, Kato H, Uemura K, Kusano G, Ito J, Chikuma T, Hojo H (2009) Inhibition of nucleoside transport and synergistic potentiation of methotrexate cytotoxicity by cimicifugoside, a triterpenoid from Cimicifuga simplex. Eur J Pharm Sci 38:355–361PubMedCrossRefGoogle Scholar
  27. 27.
    Anderson CM, Xiong W, Geiger JD, Young JD, Cass CE, Baldwin SA, Parkinson FE (1999) Distribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporters (ENT1) in brain. J Neurochem 73:867–873PubMedCrossRefGoogle Scholar
  28. 28.
    Anderson CM, Baldwin SA, Young JD, Cass CE, Parkinson FE (1999) Distribution of mRNA encoding a nitrobenzylthioinosine-insensitive nucleoside transporter (ENT2) in rat brain. Brain Res Mol Brain Res 70:293–297PubMedCrossRefGoogle Scholar
  29. 29.
    Gray JH, Owen RP, Giacomini KM (2004) The concentrative nucleoside transporter family, SLC28. Pflugers Arch 447:728–734PubMedCrossRefGoogle Scholar
  30. 30.
    King AE, Ackley MA, Cass CE, Young JD, Baldwin SA (2006) Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol Sci 27:416–425PubMedCrossRefGoogle Scholar
  31. 31.
    Narita M, Mizoguchi H, Nagase H, Suzuki T, Tseng LF (2001) Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2, N-MePhe4, Gly-Ol5]enkephalin. J Neurosci 21:3715–3720PubMedGoogle Scholar
  32. 32.
    Lu G, Zhou QX, Kang S, Li QL, Zhao LC, Chen JD, Sun JF, Cao J, Wang YJ, Chen J, Chen XY, Zhong DF, Chi ZQ, Xu L, Liu JG (2010) Chronic morphine treatment impaired hippocampal long-term potentiation and spatial memory via accumulation of extracellular adenosine acting on adenosine A1 receptors. J Neurosci 30:5058–5070PubMedCrossRefGoogle Scholar
  33. 33.
    Sawynok J, Liu XJ (2003) Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 69:313–340PubMedCrossRefGoogle Scholar
  34. 34.
    Coe I, Zhang Y, Mckenzie T, Naydenova Z (2002) PKC regulation of the human equilibrative nucleoside transporter, hENT1. FEBS Lett 517:201–205PubMedCrossRefGoogle Scholar
  35. 35.
    Iliodromitis EK, Miki T, Liu GS, Downey JM, Cohen MV, Kremastinos DT (1998) The PKC activator PMA preconditions rabbit heart in the presence of adenosine receptor blockade: is 5′-nucleotidase important? J Mol Cell Cardiol 30:2201–2211PubMedCrossRefGoogle Scholar
  36. 36.
    Kiss A, Farah K, Kim J, Garriock RJ, Drysdale TA, Hammond JR (2000) Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain. Biochem J 352(Pt 2):363–372PubMedCrossRefGoogle Scholar
  37. 37.
    Harlan RE, Kailas SR, Tagoe CE, Garcia MM (2004) Morphine actions in the rat forebrain: role of protein kinase C. Brain Res Bull 62:285–295PubMedCrossRefGoogle Scholar
  38. 38.
    Ping X, Ma Y, Li Y, Qi C, Sun X, Lv X, Cui C (2012) Essential role of protein kinase C in morphine-induced rewarding memory. Neuropharmacology 62:959–966PubMedCrossRefGoogle Scholar
  39. 39.
    Agnati LF, Fuxe K, Ruggeri M, Merlo Pich E, Benfenati F, Volterra V, Ungerstedt U, Zini I (1989) Effects of chronic treatment with uridine on striatal dopamine release and dopamine related behaviours in the absence or the presence of chronic treatment with haloperidol. Neurochem Int 15:107–113PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Wu Song
    • 1
  • Chun-Fu Wu
    • 1
  • Ping Liu
    • 1
  • Rong-Wu Xiang
    • 2
  • Fang Wang
    • 1
  • Ying-Xu Dong
    • 1
  • Jing-Yu Yang
    • 1
  1. 1.Department of PharmacologyShenyang Pharmaceutical UniversityShenyangPeople’s Republic of China
  2. 2.Mathematics Teaching & Research SectionShenyang Pharmaceutical UniversityShenyangPeople’s Republic of China

Personalised recommendations